Dyslipidemia and Intraperitoneal Inflammation Axis in Peritoneal Dialysis Patients: A Cross-Sectional Pilot Study.

BACKGROUND

We have hypothesized that the problem of dyslipidemia in peritoneal dialysis (PD) patients lies beyond certain levels of plasma lipoprotein and involves cardiovascular risk, but can also influence the development of chronic intraperitoneal inflammation.

OBJECTIVES

The aim of our work was to define whether the association of dyslipidemia with intraperitoneal inflammation really exists and if it could it be used in a prospective cohort of PD patients.

PATIENTS AND METHODS

We performed a cross-sectional, single-center, pilot study involving 40 nondiabetic PD patients (27 men and 13 women with an average age of 49.3 ± 12.2 years). The median time on PD was 29 (18.5-37) months. The parameters dialysis adequacy, blood lipid profile, and the concentrations of tumor necrosis factor (TNF)-α, monocyte chemoattractant protein (MCP)-1, and interleukin (IL)-10 in peritoneal dialysate effluent (PDE) were determined. Cohen's effect size was computed post hoc to determine the differences between groups in the concentrations of pro- and anti-inflammatory mediators.

RESULTS

PD patients with atherogenic dyslipidemia had significantly high levels of MCP-1 compared with dyslipidemia-free patients (Cohen's = 1.32). A reduced high-density lipoprotein cholesterol level was associated with a high intraperitoneal production of the proinflammatory mediator TNF-α ( < 0.0001) and anti-inflammatory IL-10 ( < 0.0001). Atherogenic index of plasma was directly correlated with MCP-1 ( < 0.0001) and TNF-α ( < 0.0001). In multiple regression analysis, MCP-1 appeared to predict PD inadequacy ( = 0.58; ratio = 9.4; = 0.006) independently of age and blood C-reactive protein level. Effect size was 1.38 with α = 0.05, = 40, and 3 predictors.

CONCLUSIONS

Our cross-sectional pilot study first demonstrated a close interaction between the atherogenic lipid profile and a high concentration of MCP-1 in PDE; this might be a prognostic marker for PD inadequacy. The potential significance of our finding is that it provides useful preliminary information necessary for further research into this area.